| Ytd | 99.88% | |
| 1y | 137.04% |
| Open | 82.36 | Prev Close | 82.43 | Low | 82.13 | High | 85.20 | Mkt Cap | 4.50B |
| Vol | 738.87K | Avg Vol | 799.48K | EPS | -4.23 | P/E | N/A | Forward P/E | -17.86 |
| Beta | 0.18 | Short Ratio | 15.00 | Inst. Own | 127.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 103.23 | 200-d Avg | 82.01 | 1yr Est | 140.80 |
Oversold health care stocks Align Technology, Dianthus Therapeutics and Ocular Therapeutix show RSI
Wall Street analysts initiated coverage on PPG, Shopify, Chesapeake Utilities, Global Payments and D
JP Morgan analyst Brian Cheng initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Ov
Citigroup analyst Samantha Semenkow initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) wit
Truist Securities analyst Danielle Brill maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Buy
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Dianthus Therapeutics (NASDAQ:DN
Wedbush analyst Laura Chico maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform and r
Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(0.90) per share which missed the
DNTH312 is an internally developed bifunctional fusion protein targeting potent inhibition of active
Evercore ISI Group analyst Gavin Clark-Gartner maintains Dianthus Therapeutics (NASDAQ:DNTH) with
Dianthus reports 75% responder rate for claseprubart in CIDP, while analysts say Sanofi's rilipr
Sanofi discontinues Phase 3 riliprubart study for CIDP due to low efficacy. SNY stock ticks up. Read
Wall Street analysts changed outlook on top names. Clear Street initiated coverage on RKLB with Buy
Analysts change outlook on top names: Truist cut KFY price target, Oppenheimer raised AZO target, B.
Wall Street analysts upgraded CRWD, ALEC, RIVN, SEDG, and DNTH. See what other analysts say about th
US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer
Dow falls 100 pts, Latham Group Inc (SWIM) rises 25.7%, Babcock & Wilcox Enterprises Inc (BW) ga
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company report